Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Positive efficacy profile reported for Zonagen's Vasomax

May 30, 1997

Ono reports AGE inhibitors and antioxidants

May 29, 1997

Kyoto describes ACAT/lipid peroxidation inhibitors

May 29, 1997

Merck & Co. acquires majority share of Gentili

May 28, 1997

Nissan Chem. reveals new antidiabetic agents

May 28, 1997

MP-52 to be developed worldwide by HMR

May 27, 1997

Lilly describes new agents for postmenopausal syndrome

May 26, 1997

Squalene synthase inhibitors from Takeda

May 26, 1997

Celtrix receives additional U.S. patents

May 23, 1997

Alora launched in U.S.

May 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...